Erlanger Health System has expanded its partnership with Tennessee Oncology to assume provision of medical oncology and hematology care to patients.
The expanded partnership provides patients with access to additional resources, clinical trials, therapeutics, and predictive data benefiting treatment and patient outcomes. There will be no lapse in care for current patients.
Janet Kramer-Mai, director of Erlanger Oncology, said, “We are excited to expand our partnership with Tennessee Oncology and provide the highest quality of cancer treatment to our community. We are dedicated to providing the right treatment, at the right time to our patients and keep them home in their community.”
“We are delighted to be partnering with Erlanger to provide state-of-the art care to patients with cancer and blood disorders,” said Dr. Matt Graham, Tennessee Oncology. “Patients throughout the region will benefit from this renewed partnership.”
Erlanger will continue to operate and expand the services offered at the Outpatient Infusion Centers located at Erlanger Baroness and Erlanger East Hospitals.
To learn more about Erlanger’s Oncology and Hematology programs visit erlanger.org/cancer.